Neurology

CGRPs Promising for Prevention of Chronic Cluster Headache



Treatment with CGRP monoclonal antibodies may reduce the frequency of chronic cluster headache attacks in patients with an inadequate response to other preventive medications, new research shows.
Medscape Medical News

Source link

Related posts

clinical neurology; +103 new citations

Newsemia

Spotlight on the October 29 issue

Newsemia

What’s the Secret to Lasting Health and Happiness?

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World